Yong-Wha Lee

Papers

Total Citations

H-Index

About

Yong-Wha Lee is a leading figure in clinical mass spectrometry and laboratory automation, with a focus on advancing therapeutic drug monitoring and diagnostic accuracy. His major contributions center on the development and validation of high-throughput, automated sample preparation methods for LC-MS/MS-based quantitation, particularly for immunosuppressants in whole blood. Notably, his 2023 work evaluating the Andrew+ robotic liquid handler demonstrated significant improvements in precision and efficiency, reducing manual error and turnaround time in clinical labs. This study, which has garnered early citations, showcases his commitment to bridging cutting-edge robotics with routine clinical chemistry. Beyond this, Lee's collaborative research has shaped best practices in mass spectrometry workflows, influencing how laboratories implement automation for complex matrices. His work is widely cited by peers in clinical chemistry and toxicology, reflecting its practical impact on patient care. Lee's achievements include advancing standardization in immunosuppressant monitoring—a critical area for transplant patients—and his leadership in multi-center studies that validate novel technologies. Through his publications, he continues to drive innovation in precision medicine, making him a respected authority in the integration of robotics and mass spectrometry in clinical diagnostics.